Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.
Felisiak-Golabek A, Dansonka-Mieszkowska A, Rzepecka IK, Szafron L, Kwiatkowska E, Konopka B, Podgorska A, Rembiszewska A, Kupryjanczyk J. Felisiak-Golabek A, et al. Among authors: rzepecka ik. Cancer Biol Ther. 2013 Oct 1;14(10):973-81. doi: 10.4161/cbt.25966. Epub 2013 Aug 14. Cancer Biol Ther. 2013. PMID: 24022213 Free PMC article.
Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.
Kupryjańczyk J, Dansonka-Mieszkowska A, Moes-Sosnowska J, Plisiecka-Hałasa J, Szafron L, Podgórska A, Rzepecka IK, Konopka B, Budziłowska A, Rembiszewska A, Grajkowska W, Spiewankiewicz B. Kupryjańczyk J, et al. Among authors: rzepecka ik. Pol J Pathol. 2013 Dec;64(4):238-46. doi: 10.5114/pjp.2013.39331. Pol J Pathol. 2013. PMID: 24375037 Free article.
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.
Felisiak-Golabek A, Rembiszewska A, Rzepecka IK, Szafron L, Madry R, Murawska M, Napiorkowski T, Sobiczewski P, Osuch B, Kupryjanczyk J; Polish Ovarian Cancer Study Group (POCSG). Felisiak-Golabek A, et al. Among authors: rzepecka ik. J Ovarian Res. 2011 Nov 10;4(1):20. doi: 10.1186/1757-2215-4-20. J Ovarian Res. 2011. PMID: 22075440 Free PMC article.
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival.
Lisowska KM, Olbryt M, Student S, Kujawa KA, Cortez AJ, Simek K, Dansonka-Mieszkowska A, Rzepecka IK, Tudrej P, Kupryjańczyk J. Lisowska KM, et al. Among authors: rzepecka ik. J Cancer Res Clin Oncol. 2016 Jun;142(6):1239-52. doi: 10.1007/s00432-016-2147-y. Epub 2016 Mar 30. J Cancer Res Clin Oncol. 2016. PMID: 27028324 Free PMC article.
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.
Dansonka-Mieszkowska A, Szafron LM, Moes-Sosnowska J, Kulinczak M, Balcerak A, Konopka B, Kulesza M, Budzilowska A, Lukasik M, Piekarska U, Rzepecka IK, Parada J, Zub R, Pienkowska-Grela B, Madry R, Siwicki JK, Kupryjanczyk J. Dansonka-Mieszkowska A, et al. Among authors: rzepecka ik. Oncotarget. 2018 Apr 3;9(25):17735-17755. doi: 10.18632/oncotarget.24878. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707144 Free PMC article.
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.
Kalachand RD, Stordal B, Madden S, Chandler B, Cunningham J, Goode EL, Ruscito I, Braicu EI, Sehouli J, Ignatov A, Yu H, Katsaros D, Mills GB, Lu KH, Carey MS, Timms KM, Kupryjanczyk J, Rzepecka IK, Podgorska A, McAlpine JN, Swisher EM, Bernards SS, O'Riain C, O'Toole S, O'Leary JJ, Bowtell DD, Thomas DM, Prieske K, Joosse SA, Woelber L, Chaudhry P, Häfner N, Runnebaum IB, Hennessy BT. Kalachand RD, et al. Among authors: rzepecka ik. J Natl Cancer Inst. 2020 Dec 14;112(12):1190-1203. doi: 10.1093/jnci/djaa070. J Natl Cancer Inst. 2020. PMID: 32413141 Free PMC article. Review.
35 results